Menu

Viracta Therapeutics, Inc. VIRX

Full chart Compare
Set alert

Price alert · VIRX

All alert types
0.01 USD 0.00 (+0.00%)

At closeJul 2, 2026, 4:00 PM EDT

0.07 +0.06 +625.97%

After hours · Jul 2, 4:00 PM ET

0.00978 Day range 0.00978
0.13 52-week range 1.31
YTD
-93.92%
1 year
-93.89%

Revenue & Expenses

Other Income → Expenses: $472.00KExpenses → Selling, General & Admin: $9.95MExpenses → Research & Development: $15.41MExpenses → Interest Expense: $514.00KGross Profit → Expenses: $2.07MRevenue → Gross Profit: $2.07MNet Loss → Expenses: $23.33MOther Income$472.00KGross Profit$2.07MNet Loss$23.33MExpenses$25.88MSelling, General & Admin$9.95MResearch & Development$15.41MInterest Expense$514.00KRevenue$2.07M

Latest period ending Dec 31, 2023 · select a line to chart its full history

VIRX annual income statement
Fiscal yearFY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021FY 2020 Dec 31, 2020FY 2019 Dec 31, 2019
-50.69M-50.59M-114.28M-18.82M-23.29M
-51.06M-49.20M-114.76M-19.02M-23.33M
-1.32-1.30-3.60-58.56-9.40
VIRX annual balance sheet
Fiscal yearFY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021FY 2020 Dec 31, 2020FY 2019 Dec 31, 2019
12.32M36.77M103.55M47.09M18.26M
56.69M95.99M108.55M48.30M37.24M
38.37M34.89M14.18M94.50M9.70M
25.56M25.16M5.48M6.18M6.28M
18.32M61.10M94.37M-46.20M27.54M
VIRX annual cash flow
Fiscal yearFY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021FY 2020 Dec 31, 2020FY 2019 Dec 31, 2019
-39.89M-35.46M-18.85M-16.05M-22.18M
15.00M-53.87M12.89M-55.00K-16.29M
438.00K22.54M62.42M44.98M43.03M
-138.00K-45.00K-252.00K-55.00K0
-24.46M-66.78M56.47M28.87M4.57M